Terms: = Prostate cancer AND TPM4, P67936, 7171, ENSG00000167460
4 results:
1. SATB1, genomic instability and Gleason grading constitute a novel risk score for prostate cancer.
Dumke C; Gemoll T; Oberländer M; Freitag-Wolf S; Thorns C; Glaessgen A; Klooster R; van der Maarel SM; Widengren J; Doehn C; Auer G; Habermann JK
Sci Rep; 2021 Dec; 11(1):24446. PubMed ID: 34961766
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant
Bjerre MT; Strand SH; Nørgaard M; Kristensen H; Rasmussen AK; Mortensen MM; Fredsøe J; Mouritzen P; Ulhøi B; Ørntoft T; Borre M; Sørensen KD
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866497
[TBL] [Abstract] [Full Text] [Related]
3. Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer.
Massard C; Chi KN; Castellano D; de Bono J; Gravis G; Dirix L; Machiels JP; Mita A; Mellado B; Turri S; Maier J; Csonka D; Chakravartty A; Fizazi K
Eur J Cancer; 2017 May; 76():36-44. PubMed ID: 28282611
[TBL] [Abstract] [Full Text] [Related]
4. DNA methylation of PITX2 predicts poor survival in men with prostate cancer.
Vasiljević N; Ahmad AS; Carter PD; Fisher G; Berney DM; Foster CS; Cuzick J; Lorincz AT
Biomark Med; 2014; 8(9):1143-50. PubMed ID: 25402584
[TBL] [Abstract] [Full Text] [Related]
